Stem cell anti-ageing therapy uses either exosome-rich mesenchymal stem cell (MSC) extracts or cultured stem cell infusions to deliver growth factors, cytokines, and signalling molecules that promote cellular regeneration. These bioactive factors help repair damaged tissues, stimulate collagen production, reduce systemic inflammation, and support mitochondrial function — addressing ageing at a fundamental cellular level rather than masking symptoms.
Patients commonly report improvements in skin quality (brighter, firmer, more hydrated skin), increased energy and stamina, improved sleep quality, enhanced mental clarity and focus, joint comfort, and a general sense of vitality. Results vary based on individual health status and the specific protocol used. Most patients notice initial changes within 4–8 weeks, with progressive improvements over 3–6 months as cellular regeneration processes are activated.
At Vivardi Clinics, stem cell anti-ageing therapy is administered via IV infusion in a clinical setting, typically lasting 60–90 minutes per session. A thorough health assessment, including blood work and medical history review, is conducted before any treatment. Our doctors design a personalised protocol based on your health goals, age, and baseline biomarkers.
Most protocols involve 1–3 sessions per treatment course, spaced 2–4 weeks apart. Booster sessions every 6–12 months are recommended for sustained benefits. Results are cumulative — many patients find that each subsequent session builds on the improvements of the previous one, especially when combined with a healthy lifestyle and complementary anti-ageing therapies.
Stem cell-derived therapies and exosome treatments are administered under strict medical supervision at Vivardi Clinics. All products used are from regulated, quality-controlled sources. Side effects are generally minimal — mild fatigue or flushing during infusion is possible. A comprehensive pre-treatment medical screening ensures treatment is appropriate and safe for each patient. We comply fully with Malaysian Ministry of Health guidelines for cell-based therapies.